KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Ionis Pharmaceuticals (IONS) Shares Issued: 2009-2025

Historic Shares Issued for Ionis Pharmaceuticals (IONS) over the last 14 years, with Sep 2025 value amounting to $81.3 million.

  • Ionis Pharmaceuticals' Shares Issued fell 83.39% to $81.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $84.8 million, marking a year-over-year decrease of 84.75%. This contributed to the annual value of $489.1 million for FY2024, which is 889.28% up from last year.
  • According to the latest figures from Q3 2025, Ionis Pharmaceuticals' Shares Issued is $81.3 million, which was up 6,213.83% from $1.3 million recorded in Q2 2025.
  • Ionis Pharmaceuticals' Shares Issued's 5-year high stood at $489.1 million during Q3 2024, with a 5-year trough of -$48,000 in Q2 2021.
  • Moreover, its 3-year median value for Shares Issued was $2.6 million (2024), whereas its average is $59.1 million.
  • Its Shares Issued has fluctuated over the past 5 years, first slumped by 100.55% in 2021, then soared by 13,012.60% in 2024.
  • Over the past 5 years, Ionis Pharmaceuticals' Shares Issued (Quarterly) stood at -$48,000 in 2021, then skyrocketed by 3,462.50% to $343,000 in 2022, then skyrocketed by 11,783.97% to $40.8 million in 2023, then crashed by 99.93% to $27,000 in 2024, then tumbled by 83.39% to $81.3 million in 2025.
  • Its Shares Issued was $81.3 million in Q3 2025, compared to $1.3 million in Q2 2025 and $2.2 million in Q1 2025.